Sleep-Wake-Disorders

August 21, 2019

Wakix is a selective H3 receptor antagonist/inverse agonist and the first treatment for narcolepsy that is not scheduled as a controlled substance.

Diana Ernst, RPh

August 21, 2019

The FDA has rejected the supplemental New Drug Application for Hetlioz (tasimelteon; Vanda Pharmaceuticals) for the treatment of jet lag disorder.

June 14, 2019

Simple tweaks to eating and sleeping patterns of “night owls” can lead to significant improvements in sleep/wake timing.

Steve Duffy

October 19, 2017

Over 33% of older adults have reported using medication to help them sleep.

Sheila Jacobs

October 10, 2017

The treatment was effective in patients with autism with or without comorbid ADHD or neurogenetic disorders.

Next post in Autism Spectrum Disorder

Preemptive Intervention Reduces Autism Symptoms, Diagnosis in Early Childhood